Celanese Corp
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
23. Earnings (Loss) Per Share
- Earnings (Loss) Per Share
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (In $ millions, except share data) | |||
| Amounts attributable to Celanese Corporation | |||
| Earnings (loss) from continuing operations | (1,144) | (1,534) | 1,952 |
| Earnings (loss) from discontinued operations | (21) | (8) | (9) |
| Net earnings (loss) | (1,165) | (1,542) | 1,943 |
| Weighted average shares - basic | 109,530,303 | 109,273,779 | 108,848,962 |
| Incremental shares attributable to equity awards(1) | — | — | 530,702 |
| Weighted average shares - diluted | 109,530,303 | 109,273,779 | 109,379,664 |
(1)Excludes anti-dilutive incremental shares attributable to equity awards as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (In shares ) | |||
| Options to purchase shares of Common Stock | 682,886 | 265,922 | 202,876 |
| Equity award shares | 68,163 | 61 | 39,465 |
In addition, the Company incurred a net loss from continuing operations for the years ended December 31, 2025 and 2024, resulting in 212,781 and 239,886, respectively, incremental shares attributable to equity awards being excluded from the number of weighted average shares - diluted as their effect would be antidilutive.
- Other (Charges) Gains, Net
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (In $ millions) | |||
| Restructuring(1) | (68) | (107) | (52) |
| Asset impairment losses(2) | (1,513) | (1,639) | (15) |
| Plant/office closures | — | 2 | (1) |
| Total | (1,581) | (1,744) | (68) |
(1)Includes employee termination benefits as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (In $ millions) | |||
| Company-wide business optimization projects | (56) | (33) | (46) |
| Lanaken, Belgium (Note 4) | (7) | — | — |
| Uentrop, Germany (Note 4) | — | (16) | — |
| Mechelen, Belgium (Note 4) | (3) | (55) | — |
| Other | (2) | (3) | (6) |
| Total | (68) | (107) | (52) |
(2)Asset impairment losses are as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (In $ millions) | |||
| Goodwill (Note 9) | (1,140) | (1,517) | — |
| Indefinite-lived intangible assets (Note 9) | (346) | (117) | — |
| Long-lived assets | (27) | (5) | (15) |
| Total | (1,513) | (1,639) | (15) |
Long-lived asset impairment losses are included in the Engineered Materials segment.
The changes in the restructuring liabilities by business segment are as follows:
| EngineeredMaterials | AcetylChain | Other | Total | |
|---|---|---|---|---|
| (In $ millions) | ||||
| Employee Termination Benefits | ||||
| As of December 31, 2023 | 13 | 2 | 3 | 18 |
| Additions | 89 | 1 | 16 | 106 |
| Cash payments | (40) | (2) | (13) | (55) |
| Other changes | (2) | (1) | — | (3) |
| Exchange rate changes | (3) | — | — | (3) |
| As of December 31, 2024 | 57 | — | 6 | 63 |
| Additions | 39 | 11 | 18 | 68 |
| Cash payments | (80) | (2) | (20) | (102) |
| Other changes | (4) | — | 4 | — |
| Exchange rate changes | 2 | — | — | 2 |
| As of December 31, 2025 | 14 | 9 | 8 | 31 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.